SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-005309
Filing Date
2020-03-30
Accepted
2020-03-30 17:30:45
Documents
17
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1680373
2 ex4-3.htm EX-4.3 5448
3 ex10-24.htm EX-10.24 345014
4 ex10-25.htm EX-10.25 130435
5 ex10-26.htm EX-10.26 26139
6 ex21-1.htm EX-21.1 6771
7 ex23-1.htm EX-23.1 4228
8 ex31.htm EX-31 34149
9 ex32.htm EX-32 8587
10 image_001.jpg GRAPHIC 18644
11 image_002.jpg GRAPHIC 18791
12 image_003.jpg GRAPHIC 17162
13 image_004.jpg GRAPHIC 17992
14 image_005.jpg GRAPHIC 9094
15 image_006.jpg GRAPHIC 24837
16 image_007.jpg GRAPHIC 26823
17 image_008.jpg GRAPHIC 17790
  Complete submission text file 0001493152-20-005309.txt   2451227
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38519 | Film No.: 20758613
SIC: 2834 Pharmaceutical Preparations